Your browser doesn't support javascript.
loading
Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy.
Xu, Qianhui; Liu, Shuhu; Zhang, Peng; Wang, Zhen; Chang, Xin; Liu, Yulu; Yan, Jiahe; He, Ruirong; Luo, Xiaoguang; Zou, Liang-Yu; Chu, Xiaofan; Guo, Yi; Huang, Suli; Fu, Xuejun; Huang, Ying.
Afiliação
  • Xu Q; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Liu S; Department of Research and Development, Guangzhou Weimi Bio-Tech Co., Ltd, Guangzhou, China.
  • Zhang P; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Wang Z; Department of Nephrology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Chang X; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Liu Y; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Yan J; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • He R; Department of Psychiatry, Third Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
  • Luo X; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Zou LY; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Chu X; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Guo Y; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Huang S; Department of Environment and Health, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
  • Fu X; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
  • Huang Y; Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Front Immunol ; 12: 759187, 2021.
Article em En | MEDLINE | ID: mdl-34675937

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Glomerulonefrite Membranosa / Contactina 1 Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Glomerulonefrite Membranosa / Contactina 1 Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça